BAILARD, INC. Q1 2024 Filing

Filed May 8, 2024

Portfolio Value

$3.6B

Holdings

731

Report Date

Q1 2024

Filing Type

13F-HR

All Holdings (731 positions)

StockValue
INZYINOZYME PHARMA INC
$186K
LQDTLIQUIDITY SVCS INC
$186K
VTRSVIATRIS INC
$185K
PETQEURPETIQ INC
$183K
TNYATENAYA THERAPEUTICS INC
$172K
GDRXGOODRX HLDGS INC
$165K
CSTECAESARSTONE LTD
$162K
ALITALIGHT INC
$162K
CYHCOMMUNITY HEALTH SYS INC NEW
$159K
LAURLAUREATE EDUCATION INC
$152K
FFFUTUREFUEL CORP
$151K
SPNTSIRIUSPOINT LTD
$150K
HGHAMILTON INSURANCE GROUP LTD
$145K
TRVITREVI THERAPEUTICS INC
$141K
LXPUSDLXP INDUSTRIAL TRUST
$140K
VYGRVOYAGER THERAPEUTICS INC
$128K
IONQIONQ INC
$126K
SIGASIGA TECHNOLOGIES INC
$122K
HOUSANYWHERE REAL ESTATE INC
$118K
ORGOORGANOGENESIS HLDGS INC
$115K
SG3SIGMATRON INTL INC
$113K
ATHIRA PHARMA INC
$111K
LCUTLIFETIME BRANDS INC
$110K
SPROSPERO THERAPEUTICS INC
$105K
NHSNEUBERGER BERMAN HIGH YIELD
$87K
RDWREDWIRE CORPORATION
$56K
HBIOHARVARD BIOSCIENCE INC
$56K
CIGCIA ENERGETICA DE MINAS GERA
$47K
OVIDOVID THERAPEUTICS INC
$38K
AKILI INC
$11K
OPTTOCEAN PWR TECHNOLOGIES INC
$9K
PreviousPage 8 of 8